Revolutionising medtech with 3D bioprinting: Interview with CELLINK co-founder and CEO Erik Gatenholm

Gothenburg-based Cellink is a 3D bioprinting company and was one of the first companies in the world to offer 3D printable bioink, which is used to print human organs and tissues. In just three years of existence, the company has been able to commercialise products used in more than 600 labs and 50 countries. The startup has made such advances as creating the first 3D bioprinted cornea, and recently came out with the first holographic bioprinter called Holograph X. In 2017, Cellink’s IPO was more than 1070% over-subscribed and the founder Erik Gatenholm was also placed on the Forbes’ “30 under 30” list in 2018.

Below, we interview Erik about his background, 3D bioprinting, CELLINK’s journey, the evolution of medtech, his advice to other startup founders, and more!

More News